CELSION CORP
10-Q/A, 1999-07-12
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Previous: TCBY ENTERPRISES INC, 10-Q, 1999-07-12
Next: LBO CAPITAL CORP, 8-K, 1999-07-12




                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 10-Q/A

(Mark One)

[X]      QUARTERLY  REPORT  PURSUANT  TO SECTION  13 OR 15(d) OF THE  SECURITIES
         EXCHANGE ACT OF 1934

                  For the Quarterly Period ended March 31, 1999

                                       or

[ ]      TRANSITION  REPORT  PURSUANT  TO SECTION 13 OR 15(d) OF THE  SECURITIES
         EXCHANGE ACT OF 1934

             For the transition period from            to
                                            -----------  -----------

Commission file number 000-14242

                               CELSION CORPORATION
             ------------------------------------------------------
             (Exact name of registrant as specified in its charter)

         Maryland                                    52-1256615
- ------------------------------              ------------------------------------
State or other jurisdiction of              (I.R.S. Employer Identification No.)
incorporation or organization

              10220-I Old Columbia Road
                  Columbia, Maryland                       21046-1705
         ----------------------------------------          ----------
         (Address of principal executive offices)          (Zip Code)

Registrant's telephone number, including area code:         (410) 290-5390
                                                            --------------
Securities registered pursuant to Section 12(b) of the Act: None
                                                            ----
Securities registered pursuant to Section 12(g) of the Act: Common Stock, par
                                                            -----------------
                                                            value $.01 per share
                                                            --------------------
                                                              (Title of Class)

         Indicate by check mark whether the Registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the  Securities  Exchange  Act of
1934  during  the  preceding  12 months  (or for such  shorter  period  that the
Registrant was required to file such reports),  and (2) has been subject to such
filing requirements for the past 90 days. Yes X No

         As of March 31, 1999, the Registrant had outstanding  45,850,136 shares
of Common Stock, $.01 par value.


<PAGE>

<TABLE>
                               CELSION CORPORATION
                            STATEMENTS OF CASH FLOWS
                                   (Unaudited)
<CAPTION>

                                                           Six Months Ended March 31
                                                           -------------------------

                                                             1999            1998
<S>                                                       <C>            <C>
Cash flows from operating activities:

  Net (loss) income                                       $(1,160,894)   $(1,914,181)

  Noncash items included in net (loss) income:

  Depreciation and amortization                                14,246          9,947

  Net changes in:

  Accounts receivable                                            (150)       (27,241)

  Inventories                                                    --          (58,268)

  Prepaid expenses                                             57,931           (210)

  Other current assets                                           --          (18,449)

  Accounts payable-trade                                     (337,704)       209,420

  Accrued interest payable - related parties                      233       (143,205)

  Accrued interest payable - other                           (108,074)        36,639

  Accrued compensation                                        137,731         28,501

  Accrued professional fees                                      --          (63,204)

  Other accrued liabilities and deferred revenue                9,665          5,033
                                                          -----------    -----------
      Net cash (used) provided by operating activities     (1,387,016)    (1,935,218)
                                                          -----------    -----------
Cash flows from investing activities:

  Purchase of property and equipment                             --           26,394

 Investment in patents                                           --          (10,000)
                                                          -----------    -----------
       Net cash provided (used) by investing activities          --           16,394
                                                          -----------    -----------
Cash flows from financing activities:

  Payment on notes payable (net)                             (154,041)       (89,522)

  Payment on capital leases (net)                                (542)          --

  Proceeds of stock issuances                               1,678,768      1,853,876
                                                          -----------    -----------
       Net cash provided by financing activities            1,524,185      1,764,354
                                                          -----------    -----------
Net increase (decrease) in cash                               137,169       (154,470)

Cash at beginning of period                                    54,920        267,352
                                                          -----------    -----------
Cash at end of the period                                     192,089    $   112,882
                                                          ===========    ===========
</TABLE>

See accompanying notes.

<PAGE>
                                   SIGNATURES

    Pursuant to the  requirements  of the  Securities  Exchange Act of 1934, the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.

    DATE:  June 12, 1999

                                       CELSION CORPORATION
                                       -------------------
                                       (Registrant)



                                       By:/s/  Spencer J. Volk
                                          --------------------------------------
                                          Spencer J. Volk
                                          President and Chief  Executive Officer


                                       By:/s/ John Mon
                                          --------------------------------------
                                          John Mon
                                          Treasurer and Chief Accounting Officer




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission